Mengesha M, Chekole T, Hidru H
BMC Womens Health. 2023; 23(1):338.
PMID: 37370091
PMC: 10294344.
DOI: 10.1186/s12905-023-02479-w.
Bonas M, Discacciati M, Videira H, Cavalcante L, Teixeira J, Vale D
Womens Health Rep (New Rochelle). 2022; 3(1):601-607.
PMID: 35814605
PMC: 9258792.
DOI: 10.1089/whr.2022.0024.
Liu Q, Zhou X, Zhang X, Strickland A, Zheng W, Chen H
Cancer Manag Res. 2021; 13:6869-6877.
PMID: 34512026
PMC: 8421554.
DOI: 10.2147/CMAR.S328279.
Stier E, Engels E, Horner M, Robinson W, Qiao B, Hayes J
AIDS. 2021; 35(11):1851-1856.
PMID: 34049357
PMC: 8373779.
DOI: 10.1097/QAD.0000000000002962.
de Carvalho N, Silva R, Val I, Bazzo M, da Silveira M
Rev Soc Bras Med Trop. 2021; 54(suppl 1):e2020790.
PMID: 34008731
PMC: 8210485.
DOI: 10.1590/0037-8682-790-2020.
Compliance with cervical cancer screening guidelines in young female patients: rates and trends of screening in New Haven County, CT.
Oliveira C, Hosier H, Pate B, Niccolai L, Sheth S, Vash-Margita A
Am J Obstet Gynecol. 2019; 221(5):530-532.
PMID: 31279847
PMC: 6829042.
DOI: 10.1016/j.ajog.2019.07.002.
Toll-like receptors: Important immune checkpoints in the regression of cervical intra-epithelial neoplasia 2.
Halec G, Scott M, Farhat S, Darragh T, Moscicki A
Int J Cancer. 2018; 143(11):2884-2891.
PMID: 30121951
PMC: 6419742.
DOI: 10.1002/ijc.31814.
Atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion triage in Korean women: Revisiting the 2012 American Society of Colposcopy and Cervical Pathology screening guidelines.
Hyun J, Min K, Yang S, Lee J, Hong J
Obstet Gynecol Sci. 2017; 60(4):357-361.
PMID: 28791267
PMC: 5547083.
DOI: 10.5468/ogs.2017.60.4.357.
A review of screening strategies for cervical cancer in human immunodeficiency virus-positive women in sub-Saharan Africa.
Viviano M, Debeaudrap P, Tebeu P, Fouogue J, Vassilakos P, Petignat P
Int J Womens Health. 2017; 9:69-79.
PMID: 28203108
PMC: 5298303.
DOI: 10.2147/IJWH.S103868.
Ecological Association of Human Papillomavirus Vaccination with Cervical Dysplasia Prevalence in the United States, 2007-2014.
Flagg E, Torrone E, Weinstock H
Am J Public Health. 2016; 106(12):2211-2218.
PMID: 27736208
PMC: 5105011.
DOI: 10.2105/AJPH.2016.303472.
Clinical Utility of Molecular Biomarkers in Cervical Squamous Intraepithelial Lesions in a Young Adult Population.
Spiryda L, Whitaker K, Messersmith A, Banister C, Creek K, Pirisi-Creek L
J Low Genit Tract Dis. 2015; 20(1):26-30.
PMID: 26579841
PMC: 4691357.
DOI: 10.1097/LGT.0000000000000163.
Progression or Regression? - Strengths and Weaknesses of the New Munich Nomenclature III for Cervix Cytology.
Tempfer C, Schiermeier S, Reinecke J, Ruppenkamp C, Hilal Z
Geburtshilfe Frauenheilkd. 2015; 75(10):1051-1057.
PMID: 26556907
PMC: 4629992.
DOI: 10.1055/s-0035-1557904.
Current Cervical Carcinoma Screening Guidelines.
Schlichte M, Guidry J
J Clin Med. 2015; 4(5):918-32.
PMID: 26239455
PMC: 4470206.
DOI: 10.3390/jcm4050918.
Cervical intraepithelial lesions in females attending Women's Health Clinics in Alexandria, Egypt.
Abdel-Hadi M, Khalaf A, Aboulkassem H, Naeem N, Baqy M, Sallam H
Cytojournal. 2015; 12:13.
PMID: 26195985
PMC: 4485213.
DOI: 10.4103/1742-6413.159240.
Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management.
Cuzick J, Myers O, Hunt W, Saslow D, Castle P, Kinney W
Int J Cancer. 2014; 136(12):2854-63.
PMID: 25447979
PMC: 4737644.
DOI: 10.1002/ijc.29337.
New cervical cancer screening guidelines: was the annual pap too much of a good thing?.
Fields M
J Adv Pract Oncol. 2014; 4(1):59-64.
PMID: 25031982
PMC: 4093371.
DOI: 10.6004/jadpro.2013.4.1.7.
Cervical Cytology and Human Papillomavirus Testing in Adolescent Women: Implications in Management of a Positive HPV Test.
Rosa M, Mohammadi A
Patholog Res Int. 2014; 2014:165690.
PMID: 24778896
PMC: 3981476.
DOI: 10.1155/2014/165690.
Cervical excisional treatment of young women: a population-based study.
Kinney W, Hunt W, Dinkelspiel H, Robertson M, Cuzick J, Wheeler C
Gynecol Oncol. 2014; 132(3):628-35.
PMID: 24395062
PMC: 3992337.
DOI: 10.1016/j.ygyno.2013.12.037.
Application of the Carolina Framework for Cervical Cancer Prevention.
Moss J, McCarthy S, Gilkey M, Brewer N
Gynecol Oncol. 2013; 132 Suppl 1:S33-40.
PMID: 24333357
PMC: 4020939.
DOI: 10.1016/j.ygyno.2013.12.004.
A population-based evaluation of cervical screening in the United States: 2008-2011.
Cuzick J, Myers O, Hunt W, Robertson M, Joste N, Castle P
Cancer Epidemiol Biomarkers Prev. 2013; 23(5):765-73.
PMID: 24302677
PMC: 4011954.
DOI: 10.1158/1055-9965.EPI-13-0973.